FOLFIRINOX vs CRT in Pancreatic Cancer: Is One Better? – Medscape

Written by

admin

in

  1. FOLFIRINOX vs CRT in Pancreatic Cancer: Is One Better?  Medscape
  2. Predicting resectability after neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer: a single center, retrospective trial  Frontiers
  3. Todd Aguilera: Neoadjuvant SABR Enhances Local Control in Pancreatic Cancer  Oncodaily
  4. PREOPANC-2 Phase 3 Trial in Resectable and Borderline Resectable Pancreatic Cancer  Oncodaily

Continue Reading

More posts